Sysmex

こんにちは順張りです 10月21日の順張りスクリーニングでは、 4503 アステラス製薬 6869 シスメックス の2銘柄がヒットしました アステラス製薬も直近高値を更新しており、かなり強いチャートですただ、今日わたしが選んだのは、 6869 シスメックス 理由は、アステラス製薬がすでにかなり上昇しているのに対して、シスメックスは8月後半から続いていた長い持ち合いを抜け始めたように見えること つまり、 「すでに走っている銘柄」より、「今から走り出しそうな銘柄」 を今回は選びました さらにシスメックスは、

Sysmex has put investors through a long, grinding stretch, with the share price falling 57.8% over the past 5 years. The obvious question now is whether the current ¥1,855 level is properly backed by the cash the business can generate. With the focus squa

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatics solutions, will showcase its latest innovations at the 2026 ADLM Clinical Lab Expo, July 28 - July 30 in Anaheim, Cali

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration with Sysmex (TYO: 6869), a leader in global in vitro diagnostics, to optimize Volition

Detailed price information for Sysmex Corp (SSMXF) from The Globe and Mail including charting and trades.

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, has received FDA clearance for the CN-6000 Automated Blood Coagulation Analyzer. This clearance includes the

The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Sysmex Corporation reflects the research output of authors from Sysmex Corporation who published articles in the 145 journals included

/PRNewswire/ -- Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, will introduce HNSCC-SEQ, a highly sensitive Plasma-Safe-SeqS...